Neuren Pharmaceuticals | NEU - Ebit

Aktienkurs
12.20
Täglich Wechseln
-0.13 -1.05%
Monatlich
4.90%
Jährlich
11.01%
Q2 Prognose
12.10




Ebit Veränderung Datum
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.39M 1.72M 2025-12
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Genetic Signatures AUD -6.34M 1.67M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Medical Developments International AUD -36K 12.96M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organon & Co USD 388M 28M 2025-09
Paradigm Biopharmaceuticals AUD -21.57M 11.26M 2025-12
PYC Therapeutics AUD -22.59M 3.25M 2025-12
Starpharma Holdings AUD -873K 161K 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12